(Q53296467)

English

Long-term blockade of vascular endothelial growth factor receptor-2 aggravates the diabetic renal dysfunction associated with inactivation of the Akt/eNOS-NO axis

scientific article published on October 8, 2010

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/20935017

Long-term blockade of vascular endothelial growth factor receptor-2 aggravates the diabetic renal dysfunction associated with inactivation of the Akt/eNOS-NO axis (English)

1 reference

10.1093/NDT/GFQ610

https://api.crossref.org/works/10.1093/NDT/GFQ610

30 July 2024

author name string

Hyung Wook Kim

1

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/20935017

Ji Hee Lim

2

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/20935017

Min Young Kim

3

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/20935017

Sungjin Chung

4

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/20935017

Seok Joon Shin

5

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/20935017

Hyun Wha Chung

6

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/20935017

Bum Soon Choi

7

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/20935017

Yong-Soo Kim

8

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/20935017

Yoon Sik Chang

9

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/20935017

Cheol Whee Park

10

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/20935017

language of work or name

0 references

publication date

8 October 2010

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/20935017

full work available at URL

https://academic.oup.com/ndt/article-pdf/26/4/1173/5319519/gfq610.pdf

Portable Document Format

online access status

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20935017

30 July 2024

http://ndt.oxfordjournals.org/cgi/content/abstract/26/4/1173

online access status

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20935017

30 July 2024

http://academic.oup.com/ndt/article-pdf/26/4/1173/5319519/gfq610.pdf

Portable Document Format

1 reference

10.1093/NDT/GFQ610

https://api.crossref.org/works/10.1093/NDT/GFQ610

30 July 2024

Nephrology Dialysis Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/20935017

26

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/20935017

4

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/20935017

1173-1188

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/20935017

Hypertension and antihypertensive treatment of diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ610

21 January 2018

Distinguishing diabetic nephropathy from other causes of glomerulosclerosis: an update

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ610

21 January 2018

New insights into the pathophysiology of diabetic nephropathy: from haemodynamics to molecular pathology

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ610

21 January 2018

Accelerated diabetic nephropathy in mice lacking the peroxisome proliferator-activated receptor alpha.

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ610

21 January 2018

Long-term treatment of glucagon-like peptide-1 analog exendin-4 ameliorates diabetic nephropathy through improving metabolic anomalies in db/db mice.

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ610

21 January 2018

The role of vascular endothelial growth factor (VEGF) in renal pathophysiology

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ610

21 January 2018

VEGF regulation of endothelial nitric oxide synthase in glomerular endothelial cells

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ610

21 January 2018

Angiogenesis and endothelial cell repair in renal disease and allograft rejection

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ610

21 January 2018

Vascular endothelial growth factor a signaling in the podocyte-endothelial compartment is required for mesangial cell migration and survival.

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ610

21 January 2018

Heterogeneous vascular endothelial growth factor (VEGF) isoform mRNA and receptor mRNA expression in human glomeruli, and the identification of VEGF148 mRNA, a novel truncated splice variant

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ610

21 January 2018

Abnormal angiogenesis in diabetic nephropathy.

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ610

21 January 2018

Stimulatory effect of IGF-I and VEGF on eNOS message, protein expression, eNOS phosphorylation and nitric oxide production in rat glomeruli, and the involvement of PI3-K signaling pathway

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ610

21 January 2018

Amelioration of long-term renal changes in obese type 2 diabetic mice by a neutralizing vascular endothelial growth factor antibody

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ610

21 January 2018

A neutralizing VEGF antibody prevents glomerular hypertrophy in a model of obese type 2 diabetes, the Zucker diabetic fatty rat.

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ610

21 January 2018

Vascular endothelial growth factor (VEGF) and soluble VEGF receptor FLT-1 in diabetic nephropathy.

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ610

21 January 2018

Reduction of VEGF-A and CTGF expression in diabetic nephropathy is associated with podocyte loss.

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ610

21 January 2018

Local VEGF activity but not VEGF expression is tightly regulated during diabetic nephropathy in man.

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ610

21 January 2018

Uncoupling of the VEGF-endothelial nitric oxide axis in diabetic nephropathy: an explanation for the paradoxical effects of VEGF in renal disease

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ610

21 January 2018

Nephron number and renal risk in hypertension and diabetes

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ610

21 January 2018

Diabetic kidney disease in thedb/dbmouse

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ610

21 January 2018

A stereological study of the renal glomerular vasculature in the db/db mouse model of diabetic nephropathy.

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ610

21 January 2018

Arginine-rich anti-vascular endothelial growth factor peptides inhibit tumor growth and metastasis by blocking angiogenesis

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ610

21 January 2018

Arginine-rich anti-vascular endothelial growth factor (anti-VEGF) hexapeptide inhibits collagen-induced arthritis and VEGF-stimulated productions of TNF-alpha and IL-6 by human monocytes

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ610

21 January 2018

Vascular endothelial growth factor inhibition by dRK6 causes endothelial apoptosis, fibrosis, and inflammation in the heart via the Akt/eNOS axis in db/db mice

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ610

21 January 2018

Vascular endothelial growth factor receptor-1 modulates vascular endothelial growth factor-mediated angiogenesis via nitric oxide

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ610

21 January 2018

Tumstatin peptide, an inhibitor of angiogenesis, prevents glomerular hypertrophy in the early stage of diabetic nephropathy.

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ610

21 January 2018

Major contribution of tubular secretion to creatinine clearance in mice.

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ610

21 January 2018

COMP-angiopoietin-1 ameliorates renal fibrosis in a unilateral ureteral obstruction model

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ610

21 January 2018

Renoprotective effect of COMP-angiopoietin-1 in db/db mice with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ610

21 January 2018

Managing patients treated with bevacizumab combination therapy.

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ610

21 January 2018

Angiogenesis inhibitor therapies: focus on kidney toxicity and hypertension

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ610

21 January 2018

Nephrin expression is reduced in human diabetic nephropathy: evidence for a distinct role for glycated albumin and angiotensin II.

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ610

21 January 2018

Role of VEGF in maintaining renal structure and function under normotensive and hypertensive conditions

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ610

21 January 2018

Inducible overexpression of sFlt-1 in podocytes ameliorates glomerulopathy in diabetic mice

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ610

21 January 2018

Biochemistry and molecular cell biology of diabetic complications

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ610

21 January 2018

New Insights on Oxidative Stress and Diabetic Complications May Lead to a “Causal” Antioxidant Therapy

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ610

21 January 2018

Hypoxia promotes fibrogenesis in vivo via HIF-1 stimulation of epithelial-to-mesenchymal transition

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ610

21 January 2018

Neutralization of Circulating Vascular Endothelial Growth Factor (VEGF) by Anti-VEGF Antibodies and Soluble VEGF Receptor 1 (sFlt-1) Induces Proteinuria

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFQ610

21 January 2018

Kidney International

4

75

S27

publication date

2000

1 reference

10.1093/NDT/GFQ610

https://api.crossref.org/works/10.1093/NDT/GFQ610

30 July 2024

Vascular endothelial growth factor (VEGF) and its receptors

9

1 reference

10.1093/NDT/GFQ610

https://api.crossref.org/works/10.1093/NDT/GFQ610

30 July 2024

Role of the VEGF--a signaling pathway in the glomerulus: evidence for crosstalk between components of the glomerular filtration barrier

13

1 reference

10.1093/NDT/GFQ610

https://api.crossref.org/works/10.1093/NDT/GFQ610

30 July 2024

Role of vascular endothelial growth factor in diabetic nephropathy

16

1 reference

10.1093/NDT/GFQ610

https://api.crossref.org/works/10.1093/NDT/GFQ610

30 July 2024

Kidney International. Supplement

23

77

S104

publication date

2000

1 reference

10.1093/NDT/GFQ610

https://api.crossref.org/works/10.1093/NDT/GFQ610

30 July 2024

Interstitial vascular rarefaction and reduced VEGF-A expression in human diabetic nephropathy.

25

1 reference

10.1093/NDT/GFQ610

https://api.crossref.org/works/10.1093/NDT/GFQ610

30 July 2024

Blockade of vascular endothelial growth factor signaling ameliorates diabetic albuminuria in mice

35

1 reference

10.1093/NDT/GFQ610

https://api.crossref.org/works/10.1093/NDT/GFQ610

30 July 2024

The American Journal of Pathology

39

147

1715

author name string

Iruela-Arispe

publication date

1995

1 reference

10.1093/NDT/GFQ610

https://api.crossref.org/works/10.1093/NDT/GFQ610

30 July 2024

Identifiers

10.1093/NDT/GFQ610

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/20935017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/20935017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53296467&oldid=2216341897"